These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37340919)

  • 21. Pyroptosis is related to immune infiltration and predictive for survival of colon adenocarcinoma patients.
    Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
    Sci Rep; 2022 Jun; 12(1):9233. PubMed ID: 35655081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
    Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
    World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
    Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
    Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.
    Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z
    BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition.
    Huang H; Li T; Meng Z; Zhang X; Jiang S; Suo M; Li N
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes.
    Zhou R; Gao Z; Ju Y
    BMC Bioinformatics; 2022 Oct; 23(1):418. PubMed ID: 36221049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a prognostic model for colorectal adenocarcinoma based on Zn transport-related genes identified by single-cell sequencing and weighted co-expression network analysis.
    Chen H; Zhao T; Fan J; Yu Z; Ge Y; Zhu H; Dong P; Zhang F; Zhang L; Xue X; Lin X
    Front Oncol; 2023; 13():1207499. PubMed ID: 37829346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma.
    Guo JN; Li MQ; Deng SH; Chen C; Ni Y; Cui BB; Liu YL
    Front Oncol; 2021; 11():640196. PubMed ID: 33763372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
    Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
    World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma.
    Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H
    Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
    Sun D; Yang KS; Chen JL; Wang ZB
    World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a prognostic model for mitophagy-related genes in colon adenocarcinoma: A study based on TCGA and GEO databases.
    Tang Y; Guo H; Chen L; Wang X; Chen Q; Gou L; Liu X; Wang X
    PLoS One; 2023; 18(4):e0284089. PubMed ID: 37023088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer.
    Yang X; Zhang C; Yan C; Ma L; Ma J; Meng X
    Aging (Albany NY); 2022 Nov; 14(22):9243-9263. PubMed ID: 36445321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
    Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
    J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
    Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
    Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
    Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y
    PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
    Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Characterization of RNA-Binding Proteins in Colon Adenocarcinoma Identifies a Novel Prognostic Signature for Predicting Clinical Outcomes and Immunotherapy Responses Based on Machine Learning.
    Miao Y; Yuan Q; Wang C; Feng X; Ren J; Wang C
    Comb Chem High Throughput Screen; 2023; 26(1):163-182. PubMed ID: 35379120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.